In CHC patients ghrelin and leptin levels are lower than those with T2D (with p-value <0.05) whereas IL-1α, insulin and PAI-1 levels are higher (with p-value <0.05). The gene discussed is IL1A; the disease is type 2 diabetes mellitus.